Please use this identifier to cite or link to this item:
Title: Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris
Authors: Uludağ Üniversitesi/Tıp Fakültesi/Dermatoloji Anabilim Dalı.
Başkan, Emel Bülbül
Yılmaz, Mediha
Tunalı, Şükran
Sarıcaoğlu, Hayriye
Keywords: Mycophenolate sodium
Issue Date: Dec-2009
Publisher: Wiley
Citation: Başkan, E. B. vd. (2009). "Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris". Journal of the European Academy of Dermatology and Venereology, 23(12), 1432-1434.
Abstract: Background Pemphigus is a chronic immunobullous disease, characterized by formation of blisters and erosions in skin and/or mucous membranes. This severe disease requires systemic immunosuppressive therapy. However, some patients are refractory, and long-term use of immunosuppressive agents can cause serious side-effects. Mycophenolic acid is increasingly being used as a corticosteroid-sparing agent or as monotherapy in immunosuppressive regimens. Objectives We aimed to evaluate the effectiveness of mycophenolate sodium, a sodium salt of mycophenolic acid, in the treatment of pemphigus vulgaris. Methods Six patients who were diagnosed as pemphigus vulgaris with active, refractory disease were treated with mycophenolate sodium. Three patients received mycophenolate sodium monotherapy; three patients received mycophenolate in combination with steroid. All patients were monitored regularly. Results Mycophenolate sodium was well tolerated with a similar efficacy of mycophenolate mofetil, and no side-effects have been observed. Conclusions Mycophenolate sodium appears to be an effective and safe alternative in the treatment of pemphigus vulgaris.
ISSN: 0926-9959
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.